Chairman of the Board and Chief Executive Officer | Read more
Senior Vice President and Head of IBM Consulting | Read more
Former President & CEO, Carrols Restaurant Group, Inc. | Read more
Former U.S. Health Sector Leader, Ernst & Young LLP (now known as EY LLP) | Read more
Former Chief Executive Officer, Covance Inc. | Read more
Former Chief Financial Officer, United Parcel Service, Inc. | Read more
Lead Director, Henry Schein, Inc.; and Retired Chairman, Ernst & Young, LLP (now known as EY LLP) | Read more
Former Vice President and Chief Information Officer, Harvard University | Read more
Executive Vice President, Chief Strategic Officer | Read more
National Advisor, Manatt Health Solutions; and Former President and Chief Executive Officer, Visiting Nurse Service of New York | Read more
Former President and Chief Executive Officer of Blue Cross Blue Shield Association | Read more
Former Chief Executive Officer, Reliant Pharmaceuticals, Inc.; and Former President of U.S. Human Health, Merck & Co. | Read more
Managing Director of Tuckson Health Connections, LLC; Co-Founder and Convener, Black Coalition Against COVID-19; and Co-Founder and Chairman of the Board of the Coalition For Trust in Health & Science | Read more
Chairman of the Board and Chief Executive Officer
Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental and medical practitioners, with more than 25,000 Team Schein Members worldwide and operations or affiliates in 33 countries and territories. Henry Schein is a member of the S&P 500® index. In 2023, the Company's sales reached $12.3 billion. Henry Schein has earned a top score on the Human Rights Campaign Foundation’s Corporate Equality Index since 2015.
Mr. Bergman brings to Henry Schein management and leadership experience. He is a well-known, highly regarded leader in the global health care industry. Mr. Bergman has expansive knowledge of the health care industry and macro-economic global conditions, maintains strategic relationships with chief executives and other senior management in the health care industry throughout the world and brings a unique and valuable perspective to the Company.
Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; the Columbia University Medical Center; the University of the Witwatersrand Fund; the World Economic Forum’s Health Care Governors; and the Business Council for International Understanding. Mr. Bergman is Co-Chairman of the board of directors of the Henry Schein Cares Foundation, Inc. Mr. Bergman is an honorary member of the Alpha Omega International Dental Society. Mr. Bergman is a recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University’s Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY), and The Hebrew University of Jerusalem; and Honorary Fellowship from King’s College London - Dental Institute and the International College of Dentists.
Stan and Dr. Marion Bergman and their family are active supporters of organizations fostering the arts, higher education, cultural diversity and grassroots health care and sustainable entrepreneurial economic development initiatives in the United States, Africa and other developing regions of the world.
Mr. Bergman is a graduate of The University of the Witwatersrand in South Africa, and is a South African Chartered Accountant and a NYS Certified Public Accountant (CPA). To read Mr. Bergman’s articles on LinkedIn, please click here.
View more »
2024
2023
2022
2021
2020
Older
Senior Vice President and Head of IBM Consulting
Mr. Ali is currently Senior Vice President and Head of IBM Consulting, and has been a director of Henry Schein, Inc. since 2021. He previously served as Chief Executive Officer and a director at IDG, Inc. (“IDG”), a technology media, events, and research company, from 2019 to May 2023.
Mr. Ali has extensive experience successfully growing and leading technology companies through strategic transformations. He also has experience with initiatives relating to social, ethical and environmental responsibility in the global supply chain.
Prior to IDG, Mr. Ali was President and CEO of Carbonite, Inc., a provider of SaaS security and data protection for businesses and individuals. Prior to that, Mr. Ali served as Chief Strategy Officer at HP Inc. where he played a pivotal role in the company's turnaround and led the decision process to split HP into two companies. He also served as President of Avaya, Inc. and in various executive roles at IBM.
He previously served on the board of directors of iRobot Corporation, Carbonite and City National Bank. In 2023, Mr. Ali was named to the Boston Globe’s “Tech Power Players 50,” a list of the top people influencing the technology industry in Massachusetts. Mr. Ali was named 2018 CEO of the Year by the Massachusetts Technology Leadership Council, was member of the 2018 Public Board of the Year named by the National Association of Corporate Directors, New England Chapter, was named in 2018 one of the 100 Most Powerful People in Boston by Boston Magazine, is a recipient of Mass High Tech Magazine’s 2011 MHT All-Stars Awards, was listed in 2008 as a 40-Under-40 by Boston Business Journal, and was a finalist in America’s prestigious 1988 Westinghouse Science Talent Search.
Mr. Ali received a B.S. in computer engineering, a B.A. in history, and a master’s degree in electrical engineering, each from Stanford University.
Vice Chairman of the Board and President
Mr. Breslawski has been with the Company since 1980, Vice Chairman from March 2018 – May 2024, President since 2005, and a director from 1992 – 2024. He is also a member of our Executive Management Committee. Mr. Breslawski held the position of Chief Executive Officer of our Global Dental Group from 2005 to March 2018. He also held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group. Between 1980 and 1990, Mr. Breslawski held various positions with us, including Chief Financial Officer, Vice President of Finance and Administration and Corporate Controller.
Mr. Breslawski partners with our senior leadership team to address corporate and strategic priorities and brings to the Company’s Board of Directors management and leadership experience. The Board of Directors is aided by Mr. Breslawski’s understanding of the health care business and his keen business acumen, leadership ability and interpersonal skills. He has served as Chairman of the Board of the American Dental Trade Association, Chairman of the Board of the Dental Trade Alliance Foundation, and President of the Dental Dealers of America. He is also a former member of the Leadership Council, School of Dental Medicine at Harvard University, a former board member of the Dental Life Network (formerly the National Foundation of Dentistry for the Handicapped), a former member of the Board of Governors for St. John’s University, and a former trustee of Long Island University.
Prior to joining Henry Schein, Mr. Breslawski was a certified public accountant at the national professional services firm BDO Seidman, LLP. He received his degree in accounting from St. John's University.
Former President & CEO, Carrols Restaurant Group, Inc.
Ms. Derby has been a director of Henry Schein, Inc. since 2021. She formerly served as President and Chief Executive Officer and a director of Carrols Restaurant Group, Inc., one of the largest restaurant franchisees in North America, until its acquisition by Restaurant Brands International Inc. in May 2024.
Ms. Derby brings to Henry Schein considerable experience across a wide range of industries and markets, and particular expertise in human resources, compensation, strategy, operations and supply chain management. Prior to her role at Carrols Restaurant Group, Ms. Derby was President of Horizon Group USA, Inc., a wholesaler of arts and crafts components, from 2016 until June 2020. Prior to that, Ms. Derby had an almost 15-year career at Toys "R" Us, rising to the position of President of Babies "R" Us and, ultimately, Vice Chairman of Toys "R" Us from 2013 until 2015. Before joining Toys "R" Us, Ms. Derby practiced corporate and employment law at Whirlpool Corporation and a large law firm in Michigan.
She also previously served on the board of directors of Vitamin Shoppe, Inc.
Ms. Derby received a B.A. in general studies with a concentration in economics from Harvard University and received an MBA and law degree from the University of Notre Dame.
Former U.S. Health Sector Leader, Ernst & Young LLP (now known as EY LLP)
Ms. Faig has been a director of Henry Schein, Inc. since December 2023.
Ms. Faig is a seasoned executive with extensive experience in healthcare and public accounting. After a distinguished 38-year career at Ernst & Young LLP (now known as EY LLP), she retired in July 2021. Throughout her time at EY, Ms. Faig held leadership roles in both national and regional capacities. As U.S. Health Sector Leader from 2017 to 2020, she spearheaded strategic expansion, driving significant revenue growth and market recognition for EY's healthcare offerings. Concurrently, she led the West Region's Health and Life Sciences market segment from 2019 to 2021, optimizing client services and overseeing revenue, operations, and personnel. From 1996 to 2018, she served as an audit partner, advising clients across the healthcare spectrum, from startups to large public companies. This experience provides her with a deep understanding of the industry's complexities and challenges.
Ms. Faig currently serves as a member of the board of directors of Affinia Therapeutics and QuVa Pharma, private equity–backed private businesses, and PATH, a non-profit organization focused on global health equity.
Throughout her professional career, Ms. Faig has been recognized for her leadership on matters related to diversity and inclusion. She served on EY's Gender Equity Task Force and was awarded EY’s Chairman’s Value Award and Americas Assurance Inclusive Leadership Award in recognition of her commitment to building an inclusive workplace.
Ms. Faig received a Bachelor of Business Administration in accounting from Sam Houston State University and is a certified public accountant.
Former Chief Executive Officer Covance Inc.
Mr. Herring has been a director of Henry Schein, Inc. since 2016. He served as Chief Executive Officer of Covance Inc. (“Covance”) from 2005 to 2015 and as Chairman of its Board of Directors from 2006 until its acquisition by Laboratory Corporation of America, Inc. in 2015. Prior to joining Covance, Mr. Herring held a variety of senior leadership positions with Caremark International and American Hospital Supply Corporation over the course of his 19 years with the combined companies. The Company values Mr. Herring’s more than 35 years of experience in the healthcare industry. Mr. Herring also brings to the Company comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. He previously served on the nonprofit board for University Medical Center of Princeton, on the board of the Association of Clinical Research Organizations, of which he served as Chairman, and on the board of directors of Team Health Holdings, Inc.
Mr. Herring received a Bachelor of Science in marketing from Louisiana State University.
Former Vice President and Chief Information Officer, Harvard University
Ms. Margulies has been a director of Henry Schein, Inc. since 2018. She served as Vice President and University Chief Information Officer at Harvard University from 2010 to 2021 and was responsible for information technology strategy, policies, and services that support the University’s mission of teaching, learning, and research. She also led Harvard University Information Technology, which provides IT services to 30,000 educators, students, and staff and oversees a $200 million budget and 700 staff.
Before returning to Harvard, where she had been Assistant Provost and Executive Director for Information Systems in the late 1990s, Ms. Margulies was Assistant Secretary for Information Technology and CIO for the Commonwealth of Massachusetts. In this capacity, she developed and implemented a statewide strategic plan for IT and oversaw consolidation of a vast patchwork of agency IT organizations, operations, data centers, and networks into a coherent statewide structure. Prior to her service with the Commonwealth, Ms. Margulies was founding Executive Director of Massachusetts Institute of Technology’s OpenCourseWare, the institution’s internationally acclaimed initiative to publish the teaching materials for their entire curriculum openly and freely over the Internet.
With information technology playing an increasingly important role in the Company’s business, the Company values Ms. Margulies’ more than 35 years of strategic information technology leadership and information technology expertise, including in the areas of cybersecurity policy and risk management. Ms. Margulies serves as the Board of Directors’ co-lead for the Company’s Diversity and Inclusion Council.
Ms. Margulies is a member of the board of directors of HarborOne Bancorp, Inc. and a member of its compensation committee and nominating and governance committee, and a member of the advisory board of the Advanced Cyber Security Center, a New England-based regional organization committed to strengthening its members’ cybersecurity defenses and preparing the region’s response to large scale cyber threats. Ms. Margulies previously served on the board of directors of SomaLogic, Inc.
As a former member of the Massachusetts Technology Collaborative Board (a quasi-state agency overseeing economic development in the Commonwealth), Ms. Margulies has participated in the Governor’s Trade mission to Israel to recruit cybersecurity companies to Massachusetts. She has also been recognized as the 2015 Boston CIO Leader of the Year by the Boston Business Journal along with the Boston CIO Leadership Association and, in 2017, was named by IDG Enterprises to the 2017 CIO Hall of Fame in CIP Magazine.
Ms. Margulies received a bachelor’s degree from the State University of New York at Plattsburgh.
Former Chief Financial Officer, United Parcel Service, Inc.
Mr. Kuehn has been a director of Henry Schein, Inc. since 2016. He was Chief Financial Officer of United Parcel Service, Inc. ("UPS"), a global leader in logistics, from 2008 until 2015. Prior to his appointment as CFO, Mr. Kuehn was Senior Vice President, Worldwide Sales and Marketing, leading the transformation of the sales organization to improve the global customer experience. Mr. Kuehn was UPS's first Vice President of Investor Relations, taking the company public in 1999 in one of the largest IPOs in U.S. history. Since he joined UPS as a driver in 1977, Mr. Kuehn's UPS career included leadership roles in sales and marketing, engineering, operations, and strategic cost planning. Mr. Kuehn was a member of UPS’ corporate sustainability steering committee, and he sponsored UPS’ first sustainability report and supported the sustainability activities of UPS for over 10 years.
Mr. Kuehn brings to the Company’s Board of Directors extensive experience with distribution logistics, and as the CFO of UPS for eight years, comprehensive knowledge of corporate finance and accounting. Additionally, the Company values Mr. Kuehn’s insights in strategic cost planning and the needs of global customers, as well as his strategic sustainability and environmental, social and governance experience. Mr. Kuehn serves as the Board of Directors’ advisor to the Company’s Environmental Impact Council.
Mr. Kuehn is also a director at LocatorX, a privately held company that provides accurate, inexpensive, and flexible tracking technology to companies across a variety of industries. He was previously a member of the Sustainability Accounting Standards Board (SASB) and is a former director of NCR Corporation.
Mr. Kuehn attended Yale University, received a Master of Business Administration from the University of Miami, and completed an advanced management program from the Wharton School of Business.
Lead Director, Henry Schein, Inc.; and Retired Chairman, Ernst & Young, LLP (now known as EY LLP)
Mr. Laskawy has been a director of Henry Schein, Inc. since 2002, and has served as Lead Director since 2012. Mr. Laskawy spent 40 years at Ernst & Young LLP (now known as EY LLP), retiring as Chairman and CEO of the Company in 2001. Under his leadership, the firm expanded into a global leader in assurance, tax, transaction, and advisory services.
Mr. Laskawy joined Ernst & Young in 1961. Progressing through the ranks of the audit services practice, he was admitted to the firm's partnership in 1971. He became Managing Partner of the New York Office in 1981, and in 1985 was named Vice Chairman and Managing Partner of the New York Region and a member of the firm's Management Committee. Mr. Laskawy became Chairman and CEO of Ernst & Young in 1994 and held that position until his retirement.
As a Certified Public Accountant with extensive experience, Mr. Laskawy brings to the Company’s Board of Directors exceptional skills in corporate finance and accounting, corporate governance, compliance, disclosure and international business conduct.
Mr. Laskawy previously served on the board of directors of Covetrus, Inc., Lazard Ltd. and Loews Corporation. Mr. Laskawy also previously served on the American Institute of Certified Public Accountants to review and update rules regarding auditor independence. In 2006 and 2007, he served as Chairman and Vice Chairman of the International Accounting Standards Committee Foundation, which was created by the Securities and Exchange Commission and sets accounting standards in more than 100 countries, and he served as a member of the 1999 Blue Ribbon Committee on Improving the Effectiveness of Corporate Audit Committees. Mr. Laskawy has also served on the board of directors of General Motors Corporation and was the Non-Executive Chairman of Federal National Mortgage Association (Fannie Mae).
Mr. Laskawy received a bachelor’s degree in Economics from the Wharton School of the University of Pennsylvania.
Executive Vice President, Chief Strategic Officer
Mr. Mlotek has been with Henry Schein, Inc. since 1994, serving in his current position as Executive Vice President and Chief Strategic Officer since 2012 and as a director since 1995. He is also a member of the Executive Management Committee. In his current role, Mr. Mlotek has three main priorities: worldwide merger and acquisition activity for the Company; business development, including important supplier partnership arrangements; and worldwide strategic planning.
Prior to holding his current position, Mr. Mlotek served as the Company's Senior Vice President of Corporate Business Development, and before that, upon joining the Company in 1994, was Vice President, General Counsel, and Secretary. Prior to joining Henry Schein, Mr. Mlotek was a partner in the law firm of Proskauer Rose, LLP and counsel to the Company, specializing in mergers and acquisitions, corporate reorganizations, and tax law. At Proskauer, since 1989, Mr. Mlotek worked very closely with Henry Schein on various corporate matters. Prior to joining Proskauer, Mr. Mlotek was a partner in the law firm of Feit & Ahrens.
As the Company continues to grow through strategic acquisitions, it values Mr. Mlotek’s extensive legal, merger and acquisition and business development experience as well as his drive for innovation and his entrepreneurial spirit.
Mr. Mlotek graduated from the Columbia University School of Law with high honors in 1980. He received an LL.M. in Taxation from New York University School of Law in 1985, also graduating with honors. Mr. Mlotek graduated summa cum laude with a B.S. degree in accounting from the Herbert Lehman University of City College of New York in 1977. Mr. Mlotek has been active in various charitable organizations, many of which help the perpetuation of the Yiddish language and culture. From 1996-2000, he served on the Conference of Presidents of Major American Jewish Organizations. Mr. Mlotek is a member of the New York State Bar Association.
Former Executive Vice President, Chief Financial Officer, Henry Schein, Inc.
Mr. Paladino has been a Member of the Board of Directors of Henry Schein, Inc. since 1992. He served as Executive Vice President and Chief Financial Officer at Henry Schein from 2000 to 2022. From 1993 to 2000, he served as Senior Vice President and Chief Financial Officer, from 1990 to 1992, he served as Vice President and Treasurer, and from 1987 to 1990, he served as Corporate Controller. A certified public accountant, Mr. Paladino was with BDO Seidman, LLP as Manager, General Audit and Consulting Services prior to joining Henry Schein in 1987.
During his tenure as Executive Vice President and Chief Financial Officer of Henry Schein, Mr. Paladino's responsibilities included corporate oversight of business units and direct responsibility for Corporate Finance, which included financial reporting, financial planning, treasury, investor relations, internal audit, risk management, and taxation. He was also responsible for Henry Schein Financial Services, which provides financial business services to Henry Schein's customers and works with the Corporate Business Development Group on Mergers and Acquisition activities.
Mr. Paladino led the Company through the corporate reorganization and separation from Schein Pharmaceutical in 1993 and through the IPO process in 1995.
Mr. Paladino is a member of the American Institute of CPAs, NYS Society of CPAs and the Institute of Management Accountants. He serves as Board Member for MSC Industrial Supply Co. and is a member of its audit committee and compensation committee.
He also served as a Nasdaq Listing and Hearing Review Council member. The Listing and Hearing Review Council provides advice to the Board of Directors of The Nasdaq Stock Market LLC on issues relating to listing rule and policy changes and enhancements that will protect investors and the integrity of the Nasdaq Stock Market, while ensuring the consistent and fair application and enforcement of the listing rules, procedures and policies of Nasdaq.
Mr. Paladino is the recipient of the following recognitions and awards:
Mr. Paladino holds a bachelor of business administration degree from Bernard M. Baruch College.
National Advisor, Manatt Health Solutions; and Former President and Chief Executive Officer, Visiting Nurse Service of New York
Ms. Raphael has been a director of Henry Schein, Inc. since 2012. She currently serves as a National Advisor for Manatt Health Solutions. Ms. Raphael served as the President and Chief Executive Officer of the Visiting Nurse Service of New York from 1989 to 2011. Prior to this, she held executive positions at Mt. Sinai Medical Center and in the New York City government.
Ms. Raphael has served on the Federal Bipartisan Commission on Long Term Care, the Medicare Payment Advisory Commission (MedPAC), the New York State Medicaid Redesign Team, and was an Advanced Leadership Fellow at Harvard University. She is the former Chair of the Board of the Long Term Quality Alliance and is a director emeritus of the New York eHealth Collaborative, which is implementing a statewide, standardized platform for the exchange of health information.
She previously chaired the National Quality Forum's Post-Acute, Long Term Care, and Hospice Workgroup, which brought together stakeholders to recommend quality measures as federal programs move to public reporting and value-based purchasing, and was co-chair of its Attribution Committee and a member of its All-Cause Admissions and Readmissions Standing Committee. She also co-chaired the West Health Advisory Council on Emergency Department to Home-Based Healthcare.
As a nationally recognized industry leader, Ms. Raphael brings to the Company’s Board of Directors extensive knowledge and experience in health policy, economics, management, clinical services, home healthcare, occupational health and safety and new models of integrated care (particularly for chronically ill and long term care populations). Ms. Raphael’s strategic insights into the health care needs of an aging population and her invaluable experience advancing the adoption of health information technology is valued by the Company, especially in connection with its strategic plan for growth and innovative solutions.
Ms. Raphael currently serves on several non-profit boards including the Primary Care Development Corporation, the Medicare Rights Center, the SCAN Foundation, Commonwealth Care Alliance, the Kaiser Permanente School of Medicine, and in 2016, completed her term as Chair of the national AARP board. She is also a member of several advisory boards, including the Harvard School of Public Health's Policy and Management Executive Council, the New York City Age-Friendly Commission, the New York State Quality Advisory Committee, and Honor Technology, Inc.'s Advisory Board. Ms. Raphael co-edited the book "Home Based Care for a New Century," was a Visiting Fellow at the King's Fund in the United Kingdom and was listed in Crain's New York Business 50 Most Powerful Women in 2009.
Ms. Raphael has an MPA from Harvard University's Kennedy School of Government.
Former President and Chief Executive Officer of Blue Cross Blue Shield Association
Mr. Serota has been a director of Henry Schein, Inc. since December 2021. Most recently, he was President and CEO of Blue Cross Blue Shield Association (BCBSA), a national federation of 35 independent, community-based, and locally operated Blue Cross Blue Shield companies, from 1996 until January 2021.
Mr. Serota brings to Henry Schein considerable expertise in health care insurance and public policy. Additionally, the Company values Mr. Serota’s decades-long system development and business strategy experience.
Prior to joining BCBSA, Mr. Serota was President and CEO of Chicago-based Rush Prudential Health Plans, where he led the integration of Rush-Presbyterian-St. Luke's Medical Center Health Plans and The Prudential. Earlier in his career, Mr. Serota also created and led Physicians Preferred Health Inc., a Missouri-based physician-hospital organization, and served as an administrator at Hillcrest Medical Center in Tulsa, Oklahoma. His public policy activity includes having served on the Policy Committee of the White House Conference on Aging under President George W. Bush, and as a charter member of the American Health Information Community, a federally chartered commission formed to advance health information, also by the appointment of President Bush.
He currently serves on the board of directors of Blue Cross Blue Shield of Michigan, Athletico Physical Therapy, and the Northwester Health Care Network, and is Board Chair of the Board of Trustees of the Brain Research Foundation. He is an advisory board member of Paragon Biosciences, LLC, a biotechnology company, and The Vistria Group, a private firm that invests in the healthcare industry. He previously served on the board of directors of Itamar Medical Ltd. and as an executive advisor for Castlight Health, Inc.
Among civic leadership roles, Mr. Serota served on the CEO Advisory Board for Building a Healthier Chicago, and is a member of the Advisory Board for the Schaeffer Center at the University of Southern California.
Mr. Serota received a B.S. from Purdue University, a master’s in health administration and planning from the Washington University School of Medicine, and an honorary Doctor of Science from Purdue University.
Former Chief Executive Officer, Reliant Pharmaceuticals, Inc.; and Former President of U.S. Human Health, Merck & Co.
Dr. Sheares has been a director of Henry Schein, Inc. since 2010. He most recently served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., Inc., leading that company from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health for Merck & Co., Inc. from 2001 until 2006, the culmination of a 19-year career with that company.
Dr. Sheares is the former chair of the Board of Directors of the National Pharmaceutical Council, which focuses on broadly communicating the economic, clinical, and societal value of pharmaceuticals. He also previously served as a director of Honeywell International and as a member of its management development and compensation committee and retirement plan committees, and as a director and Chairman of the compensation committee of The Progressive Corporation.
As the former Chief Executive Officer of Reliant Pharmaceuticals and with 20 years in the pharmaceutical industry, Dr. Sheares brings to the Company’s Board of Directors extensive health care knowledge and experience in sales, marketing, brand management, research and development, complex regulatory and legal issues, risk management (including supply chain risk management) and mergers and acquisitions. As a director of other public companies, Dr. Sheares has been involved in succession planning, compensation, employee management and the evaluation of acquisition opportunities.
Dr. Sheares received a bachelor's degree in chemistry from Fisk University and earned his doctorate in biochemistry from Purdue University. He completed his postdoctoral training as a Lucille P. Markey Scholar and was a National Institutes of Health Postdoctoral Fellow at the Massachusetts Institute of Technology.
Managing Director of Tuckson Health Connections, LLC; Co-Founder and Convener, Black Coalition Against COVID-19; and Co-Founder and Chairman of the Board of the Coalition For Trust in Health & Science
Dr. Tuckson has been a director of Henry Schein, Inc. since 2021. He is currently the Managing Director of Tuckson Health Connections, LLC. He is also the Co-Founder and Convener of the Black Coalition Against COVID-19 and the Co-Founder and Chairman of the Board of the Coalition For Trust in Health & Science. Prior to Tuckson Health Connections, Dr. Tuckson enjoyed a long tenure as Executive Vice President and Chief of Medical Affairs of United Health Group from 2006 until 2014.
Dr. Tuckson previously served as Senior Vice President, Professional Standards of the American Medical Association, Commissioner of Public Health for the District of Columbia, Senior Vice President of the March of Dimes Birth Defects Foundation, and President of the Charles R. Drew University of Medicine and Science. Additionally, he has been appointed to leadership roles at the National Academy of Medicine and has been a member of numerous federal advisory committees and corporate, non-profit, and academic boards, including his past service on the board of trustees of Howard University, where he served as Chair of the Health Sciences Committee. The Board values Dr. Tuckson’s more than 35 years of experience as a health care professional, his recognition as a leader in his field, and his engagement in nearly every sector of the health and medical care industries.
Dr. Tuckson currently serves on the board of directors of Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, and previously served on the board of directors of CTI BioPharma Corp.
The Company values Dr. Tuckson’s more than 35 years of experience as a healthcare professional, his recognition as a leader in his field and his engagement in nearly every sector of the health and medical care industries. Dr. Tuckson serves as the Board of Directors’ co-lead for the Company’s Diversity and Inclusion Council.
Dr. Tuckson was recognized several times as one of the "50 Most Influential Physician Executives" by Modern Healthcare Magazine, named as one of the "100 Most Powerful Executives in Corporate America" by Black Enterprise Magazine in 2009, and as "Washingtonian of the Year" by Washingtonian Magazine in 1998. He is also the author of "The Doctor in the Mirror," an ongoing book and online senior patient activation and education project.
Dr. Tuckson received a B.S. from Howard University and an M.D. from Georgetown University School of Medicine. Dr. Tuckson completed the University of Pennsylvania Hospital’s General Internal Medicine Residency and Fellowship programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.